Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v1-EN
Language French English
Date Updated 2020-09-17 2020-07-30
Drug Identification Number 02258323 02258323
Brand name TEVA-MELOXICAM TEVA-MELOXICAM
Common or Proper name TEVA-MELOXICAM 15MG TAB TEVA-MELOXICAM 15MG TAB
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients MELOXICAM MELOXICAM
Strength(s) 15MG 15MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size P Pack 30 P Pack 30
ATC code M01AC M01AC
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-07-29 2020-07-29
Estimated end date 2020-09-30 2020-09-30
Actual end date 2020-09-16
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments